Vanadium: A Panacea for Resistance to Oncolytic Immunotherapy?

  • Dmitriy Zamarin
  • Published 2018 in
    Molecular therapy : the journal of the American…

Abstract

Memorial Sloan Kettering Cancer Center, 300 East 66th Street, 1313, New York, NY 10065, USA Correspondence: Dmitriy Zamarin, MD, PhD, Memorial Sloan Kettering Cancer Center, 300 East 66th Street, 1313, New York, NY 10065, USA. E-mail: zamarind@mskcc.org Oncolytic viruses (OVs) are a class of anticancer agents that mediate therapeutic effects through some… (More)
DOI: 10.1016/j.ymthe.2017.12.006

Topics

1 Figure or Table

Slides referencing similar topics